Crescita Therapeutics Inc.
CTX.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -303.07% | -463.97% | -321.15% | -340.53% | -200.89% |
| Total Depreciation and Amortization | -8.97% | -3.70% | 0.46% | -1.32% | -1.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 157.67% | 39.98% | 108.92% | 134.98% | -83.68% |
| Change in Net Operating Assets | 310.97% | 186.23% | 119.60% | 143.58% | 66.20% |
| Cash from Operations | 722.22% | 64.50% | -31.98% | 319.82% | -82.65% |
| Capital Expenditure | -4,338.36% | -6,788.29% | 31.64% | 45.20% | 91.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,619.50% | -1,265.36% | 47.93% | 56.19% | 78.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.71% | -8.95% | 69.80% | 70.28% | 70.51% |
| Issuance of Common Stock | -100.00% | -- | 216.67% | 216.67% | 216.67% |
| Repurchase of Common Stock | -26.92% | -105.95% | -33.81% | 8.39% | 24.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Cash from Financing | -16.95% | -38.87% | 50.36% | 59.53% | 61.16% |
| Foreign Exchange rate Adjustments | -361.02% | -56.31% | -113.91% | -121.55% | -75.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.78% | -365.67% | 51.30% | 136.80% | 55.65% |
